Optical screening of diabetes mellitus using non-invasive Fourier-transform infrared spectroscopy technique for human lip

Journal of Pharmaceutical and Biomedical Analysis

Volumn 76, Issue , 2013, Pages 169-176

  Yoshida, Satoshi ^a   Yoshida, Makoto ^a   Yamamoto, Mayumi ^a   Takeda, Jun ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGEs); Diabetes screening; FTIR ATR; Hemoglobin A1c (HbA1c); Lip

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOXYMETHYL BETA CYCLODEXTRIN; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; FALSE NEGATIVE RESULT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFRARED SPECTROSCOPY; LIP; MALE; NON INVASIVE PROCEDURE; OPTICS; PARTIAL LEAST SQUARES REGRESSION; PILOT STUDY; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS; FALSE NEGATIVE REACTIONS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LEAST-SQUARES ANALYSIS; LIP; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; REGRESSION ANALYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84872461182     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.12.009     Document Type: Article

References (35)

1. Brown C.D., Davis H.T., Ediger M.N., Fleming C.M., Hull E.L., Rohrscheib M. Clinical assessment of near-infrared spectroscopy for noninvasive diabetes screening. Diab. Technol. Ther. 2005, 7:456-466.
2. Malin S.F., Ruchti T.L., Blank T.B., Thennadil S.N., Monfre S.L. Noninvasive prediction of glucose by near-infrared diffuse reflectance spectroscopy. Clin. Chem. 1999, 45:1651-1658.
3. Heise H.M., Marbach R. Human oral mucosa studies with varying blood glucose concentration by non-invasive ATR-FT-IR-spectroscopy. Cell Mol. Biol. (Noisy-le-grand). 1998, 44:899-912.
4. Khalil O.S. Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. Diab. Technol. Ther. 2004, 6:660-697.
5. Rohleder D., Kocherscheidt G., Gerber K., Kiefer W., Kohler W., Mocks J., Petrich W. Comparison of mid-infrared and Raman spectroscopy in the quantitative analysis of serum. J. Biomed. Opt. 2005, 10:031108.
6. Arnold M.A., Liu L., Olesberg J.T. Selectivity assessment of noninvasive glucose measurements based on analysis of multivariate calibration vectors. J. Diab. Sci. Technol. 2007, 1:454-462.
7. Scott D.A., Renaud D.E., Krishnasamy S., Meric P., Buduneli N., Cetinkalp S., Liu K.Z. Diabetes-related molecular signatures in infrared spectra of human saliva. Diabetol. Metab. Syndr. 2010, 2:48.
8. Monnier V.M., Bautista O., Kenny D., Sell D.R., Fogarty J., Dahms W., Cleary P.A., Lachin J., Genuth S. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999, 48:870-880.
9. Heise H.M., Haiber S., Licht M., Ihrig D.F., Moll C., Stuecker M. Recent progress in noninvasive diabetes screening by diffuse reflectance near-infrared skin spectroscopy. Proc. SPIE. 2006, 6093:609310.
10. Bradshaw C., Steen I.N., Eccles M. Glycated haemoglobin levels in patients with diabetes in one general practice over a 10-year period. Diabet. Med. 1995, 12:628-631.
11. Araszkiewicz A., Naskret D., Niedzwiecki P., Samborski P., Wierusz-Wysocka B., Zozulinska-Ziolkiewicz D. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes. Diab. Technol. Ther. 2011, 13:837-842.
12. Utzmann C.M., Lederer M.O. Independent synthesis of aminophospholipid-linked maillard products. Carbohydr. Res. 2000, 325:157-168.
13. Seino Y., Nanjo K., Tajima N., Kadowaki T., Kashiwagi A., Araki E., Ito C., Inagaki N., Iwamoto Y., Kasuga M., Hanafusa T., Haneda M., Ueki K. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J. Japan Diab. Soc. 2010, 56:450-467.
14. Yoshida S., Zhang Q.Z., Sakuyama S., Matsushima S. Metabolism of fatty acids and lipid hydroperoxides in human body monitoring with Fourier transform infrared spectroscopy. Lipids Health Dis. 2009, 8:28.
15. Sakuyama S., Hirabayashi C., Hasegawa J., Yoshida S. Analysis of human face skin surface molecules in situ by Fourier-transform infrared spectroscopy. Skin Res. Technol. 2010, 16:151-160.
16. Shoji N., Nakagawa K., Asai A., Fujita I., Hashiura A., Nakajima Y., Oikawa S., Miyazawa T. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma. J. Lipid Res. 2010, 51:2445-2453.
17. Miyata T., Wada Y., Cai Z., Iida Y., Horie K., Yasuda Y., Maeda K., Kurokawa K., van Ypersele de Strihou C. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997, 51:1170-1181.
18. Kawabata K., Yoshikawa H., Saruwatari K., Akazawa Y., Inoue T., Kuze T., Sayo T., Uchida N., Sugiyama Y. The presence of N(epsilon)-(Carboxymethyl) lysine in the human epidermis. Biochim. Biophys. Acta 2011, 1814:1246-1252.
19. Meerwaldt R., Links T.P., Graaff R., Hoogenberg K., Lefrandt J.D., Baynes J.W., Gans R.O., Smit A.J. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005, 48:1637-1644.
20. Samborski P., Naskret D., Araszkiewicz A., Niedzwiecki P., Zozulinska-Ziolkiewicz D., Wierusz-Wysocka B. Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes. Pol. Arch. Med. Wewn. 2011, 121:67-72.
21. Camargo J.L., Stifft J., Gross J.L. The effect of aspirin and vitamins C and E on HbA1c assays. Clin. Chim. Acta 2006, 372:206-209.
22. Koga M., Hashimoto K., Murai J., Saito H., Mukai M., Ikegame K., Ogawa H., Kasayama S. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin. Chim. Acta 2011, 412:253-257.
23. Gerrits E.G., Lutgers H.L., Kleefstra N., Groenier K.H., Smit A.J., Gans R.O., Bilo H.J. Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9). J. Diab.Sci. Technol. 2008, 2:572-577.
24. Dunn J.A., McCance D.R., Thorpe S.R., Lyons T.J., Baynes J.W. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 1991, 30:1205-1210.
25. Lohwasser C., Neureiter D., Weigle B., Kirchner T., Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J. Invest. Dermatol. 2006, 126:291-299.
26. Requena J.R., Ahmed M.U., Fountain C.W., Degenhardt T.P., Reddy S., Perez C., Lyons T.J., Jenkins A.J., Baynes J.W., Thorpe S.R. Carboxymethylethanolamine a biomarker of phospholipid modification during the maillard reaction in vivo. J. Biol. Chem. 1997, 272:17473-17479.
27. Sookwong P., Nakagawa K., Fujita I., Shoji N., Miyazawa T. Amadori-glycated phosphatidylethanolamine a potential marker for hyperglycemia in streptozotocin-induced diabetic rats. Lipids 2011, 46:943-952.
28. Iijima K., Murata M., Takahara H., Irie S., Fujimoto D. Identification of N(omega)-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen. Biochem. J. 2000, 347 Pt 1:23-27.
29. Odani H., Iijima K., Nakata M., Miyata S., Kusunoki H., Yasuda Y., Hiki Y., Irie S., Maeda K., Fujimoto D. Identification of N(omega)-carboxymethylarginine a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes. Biochem. Biophys. Res. Commun. 2001, 285:1232-1236.
30. Genuth S., Sun W., Cleary P., Sell D.R., Dahms W., Malone J., Sivitz W., Monnier V.M. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005, 54:3103-3111. f.t.D.S.C.A.S Group.
31. Madison K.C. Barrier function of the skin: la raison d'etre" of the epidermis. J. Invest. Dermatol. 2003, 121:231-241.
32. Pechtold L.A., Abraham W., Potts R.O. The influence of an electric field on ion and water accessibility to stratum corneum lipid lamellae. Pharm. Res. 1996, 13:1168-1173.
33. Yoshida S., Okazaki Y., Yamashita T., Ueda H., Ghadimi R., Hosono A., Tanaka T., Kuriki K., Suzuki S., Tokudome S. Analysis of human oral mucosa ex vivo for fatty acid compositions using Fourier-transform infrared spectroscopy. Lipids 2008, 43:361-372.
34. Nagase Y., Yoshida S., Kamiyama K. Analysis of human tear fluid by Fourier transform infrared spectroscopy. Biopolymers 2005, 79:18-27.
35. Geistanger A., Arends S., Berding C., Hoshino T., Jeppsson J.-O., Little R., Siebelder C., Weykamp C. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin. Chem. 2008, 54:1379-1385. on behalf of the IFCC Working Group on Standardization of Hemoglobin A1c.